A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia

NCT01925378 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study is going to open in a new site

Conditions

Cervical Dysplasia

Interventions

DRUG: Nelfinavir

Sponsor

The University of Texas Health Science Center, Houston